Molecular Genetics and Epigenetics
分子遗传学和表观遗传学
基本信息
- 批准号:8231124
- 负责人:
- 金额:$ 2.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:American Cancer SocietyAneuploidyArchitectureAwardBehaviorBioinformaticsBrain NeoplasmsCancer Center Support GrantCell CycleChromosomesChromosomes, Human, Pair 1ClinicalCollaborationsDNADNA Sequence RearrangementDataDefectDiagnosisDoctor of PhilosophyEpigenetic ProcessExtramural ActivitiesFosteringFundingGene ExpressionGeneticGenetic TranscriptionGenomicsGoalsGrantHealthHuman GenomeIndividualInstitutesLung NeoplasmsMalignant - descriptorMalignant NeoplasmsMicroRNAsMiningMolecularMolecular GeneticsMutationPreventionProto-OncogenesRadiationResearchRoleSignal TransductionSpeedTumor Suppressor Proteinsbasecancer diagnosiscohortimprovedmemberneoplastic celloutcome forecastprogramsrepairedresponsetumortumorigenesis
项目摘要
The accumulation of heritable genetic and epigenefic changes that result in loss of funcfion of tumor
suppressors and/or inappropriate activation of proto-oncogenes is a hallmark of cancer. The goals of the
Molecular Genetics and Epigenetics Program (GEN) are to understand the molecular mechanisms that
underiie these defects and to uncover new targets for therapy, diagnosis, prognosis, and prevention. The
Program capitalizes on the large number of outstanding invesfigators at UVA with research expertise in
chromafin architecture, transcription, replicafion. mutation, repair, and cellular checkpoints in cancer. The
Members are organized around four main themes: (1) Chromosome funcfion, malfunction, and cellular
checkpoints; (2) Epigenefics and cancer; (3) Signaling and gene expression in cancer; and (4) Bioinformatics:
mining informafion from human genomes. The Program is led by Joyce L. Hamlin, PhD, an expert in
mammalian DNA replicafion and large-scale chromosome rearrangements in tumor cells; and by Anindya
Dutta, MD, PhD a leader in the replicafion and cell cycle fields. Dr. Dutta has focused more recenfiy on the
role of microRNAs in tumorigenesis. Through its acfivities. GEN provides a formal mechanism for fostering
intellectual exchange and collaboration among its Members. The Program currently consists of 32 Full
Members and 6 Associate Members from 11 different departments. Twenty one of these individuals are new
to the Program or to UVA since the last renewal, and they bring considerable expertise in the bioinformatics
of microarray and deep-sequencing data, large-scale genomic rearrangements (including aneuploidy). and
the molecular effects of radiafion and cellular responses to radiation. Importanfiy for this renewal, GEN has
added a significant cohort of translafional and clinical invesfigators whose research focus is on particular
tumor types, including lung and brain tumors, or on radiafion damage. Total extramural funding for the
Program exceeds $14.8 million, including $3.4 million from the Nafional Cancer Institute (NCI) and an award
from the American Cancer Society. Program Members have produced 390 cancer-relevant publicafions, of
which 32% were inter-programmatic and 18% were intra-programmatic since the last renewal. In addition.
Program Members participate in multi-invesfigator and collaborative Nafional Insfitutes of Health research
awards, including 18 grants from NCI.
导致肿瘤功能丧失的遗传和表观遗传变化的积累
抑制子和/或原癌基因的不适当激活是癌症的标志。的目标
分子遗传学和表观遗传学计划(GEN)是了解分子机制,
这些缺陷的基础,并发现新的治疗,诊断,预后和预防的目标。的
该计划利用了大量的优秀invesfigators在弗吉尼亚大学与研究专业知识,
染色质结构、转录、复制。突变、修复和癌症细胞检查点。的
成员围绕四个主题组织:(1)染色体功能,故障和细胞
检查点;(2)表观遗传学和癌症;(3)癌症中的信号传导和基因表达;以及(4)生物信息学:
从人类基因组中挖掘信息。该项目由Joyce L.哈姆林博士,
哺乳动物DNA复制和肿瘤细胞中的大规模染色体重排;
Dutta,MD,PhD是复制和细胞周期领域的领导者.杜塔博士最近更关注
microRNA在肿瘤发生中的作用通过其活动。GEN提供了一个正式的机制,
成员之间的知识交流和合作。该计划目前包括32个完整的
来自11个不同部门的会员和6名准会员。其中21人是新来的
自上次更新以来,该计划或UVA,他们带来了生物信息学方面的大量专业知识
微阵列和深度测序数据,大规模基因组重排(包括非整倍体)。和
辐射的分子效应和细胞对辐射的反应。对于此次更新,GEN已
增加了一个重要的队列,其研究重点是
肿瘤类型,包括肺和脑肿瘤,或辐射损伤。2004 - 2005两年期校外供资共计
该计划超过1480万美元,其中包括来自国家癌症研究所(NCI)的340万美元和一个奖项
来自美国癌症协会。项目成员制作了390份与癌症有关的出版物,
自上次更新以来,32%为方案间,18%为方案内。另外。
计划成员参与多个投资者和合作的国家卫生研究机构
获奖,包括来自NCI的18笔赠款。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J. WEBER其他文献
MICHAEL J. WEBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J. WEBER', 18)}}的其他基金
Adaptive signaling exposes a therapeutic vulnerability in NRAS melanomas
适应性信号传导暴露了 NRAS 黑色素瘤的治疗脆弱性
- 批准号:
8621637 - 财政年份:2014
- 资助金额:
$ 2.87万 - 项目类别:
相似海外基金
Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
- 批准号:
10887038 - 财政年份:2023
- 资助金额:
$ 2.87万 - 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
- 批准号:
10877239 - 财政年份:2023
- 资助金额:
$ 2.87万 - 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
- 批准号:
MR/X007979/1 - 财政年份:2023
- 资助金额:
$ 2.87万 - 项目类别:
Research Grant
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
- 批准号:
10735074 - 财政年份:2023
- 资助金额:
$ 2.87万 - 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
- 批准号:
10538074 - 财政年份:2022
- 资助金额:
$ 2.87万 - 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
- 批准号:
10537275 - 财政年份:2022
- 资助金额:
$ 2.87万 - 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
- 批准号:
10661533 - 财政年份:2022
- 资助金额:
$ 2.87万 - 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
- 批准号:
10366610 - 财政年份:2022
- 资助金额:
$ 2.87万 - 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
- 批准号:
10467260 - 财政年份:2022
- 资助金额:
$ 2.87万 - 项目类别:














{{item.name}}会员




